Diagnostic Kits/Bibliography by Research Question: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
Line 40: Line 40:


= Outputs and Products of the field: data, narratives and tools produced by the Kits' sector =
= Outputs and Products of the field: data, narratives and tools produced by the Kits' sector =
* [http://www.cafc.uscourts.gov/opinions/08-1248ebo.pdf Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.] 560 F.3d 1366 C.A.Fed. (Mass., 2009)
* [http://www.cafc.uscourts.gov/opinions/06-1634.pdf Classen Immunotherapies, Inc. v. Biogen IDEC], 304 Fed. Appx. 866 (Fed. Cir. 2008)
* Correspondence and Submissions Relating to CellPro March-In Petition. (2008, April 3). Retrieved April 17, 2010, from http://www.nih.gov/icd/od/foia/cellpro/index.htm
* [http://www.patentlyo.com/08-964-chakrabarty.pdf Diamond v. Chakrabarty], 447 U.S. 303 (1980)
*Geertrui Van Overwalle et al., 2005. ''Models for facilitating access to patents on genetic inventions''. Available at: http://www.nature.com/nrg/journal/v7/n2/full/nrg1765.html [Accessed August 10, 2009].
**[[Diagnostic_Kits/Models for facilitating access to patents on genetic inventions|Highlights]]
* [http://supreme.justia.com/us/333/127/case.html Funk Brothers v. Kalo], 333 U.S. 127 (1948) ... 10-11, 15
* [http://supreme.justia.com/us/333/127/case.html Gottschalk v. Benson], 409 U.S. 63 (1972) ... 9
* Holman, Christopher M., The Impact of Human Gene Patents on Innovation and Access: A Survey of Human Gene Patent Litigation. UMKC Law Review, Vol. 76, p. 295, 2007. Available at SSRN: http://ssrn.com/abstract=1090562
* Holman, Christopher. 2008 (Nov 4). "Applying Bilski to Biotechnology and the Life Sciences." ''Patently-O.'' http://www.patentlyo.com/patent/2008/11/applying-bilski.html.
*J.D, M.A.H.P. & Munzer, S.R., Intellectual Property Rights in Genes and Gene Fragments: A Registration Solution for Expressed Sequence Tags. SSRN eLibrary. Available at: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=241236 [Accessed October 30, 2009].
* Howlett, M.J. & Christie, A.F., An Analysis of the Approach of the European, Japanese and United States Patent Offices to Patenting Partial DNA Sequences (ESTs). SSRN eLibrary. Available at: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=573184 [Accessed October 30, 2009].
* [http://www.cafc.uscourts.gov/opinions/07-1130.pdf In re Bilski], 545 F.3d 943 (C.A.Fed., 2008.).
* [http://www.uspto.gov/web/offices/com/sol/%C3%A2%C2%80%C2%8Bfedcirdecision/%C3%A2%C2%80%C2%8B04-1465.pdf  In re Fisher], 421 F.3d 1365, 1371 (Fed.Cir. 2005).
* Microbiological Research Corp. v. Muna, 625 P.2d 690, 700 (Utah 1981)
* Mueller, J.M., Public Access Versus Proprietary Rights in Genomic Information: What Is the Proper Role of Intellectual Property Rights? SSRN eLibrary. Available at: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1367849 [Accessed October 30, 2009].
* Noonan, Kevin.  2009 (Feb 5). "Applying In re Bilski to Diagnostic Method Claims." ''Patent Docs''.  http://www.patentdocs.org/2009/02/applying-in-re-bilski-to-diagnostic-method-claims.html
* Noonan, Kevin.  2009 (Sept 16). "Prometheus Laboratories, Inc. v. Mayo Collaborative Services (Fed. Cir. 2009)." ''Patent Docs''. http://www.patentdocs.org/2009/09/prometheus-laboratories-inc-v-mayo-collaborative-services-fed-cir-2009.html
* [http://faculty.law.pitt.edu/madison/patent/supplement/oreilly_v_morse.html O'Reilly v. Morse], 56 U.S. 62 (1853)
* Pressman, L. et al., 2006. ''The licensing of DNA patents by US academic institutions: an empirical survey''. Nat Biotech, 24(1), 31-39
**[[Diagnostic_Kits/The licensing of DNA patents by US academic institutions|Highlights]]
* [http://www.cafc.uscourts.gov/opinions/08-1403.pdf Prometheus Laboratories, Inc. v. Mayo Collaborative Services]. 2009 WL 2950232 C.A.Fed. (Cal.,2009).
*Verbeure, B. et al., 2006. ''Patent pools and diagnostic testing. Trends in Biotechnology'', 24(3), 115-120.(Verbeure et al. 2006) Available at: http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TCW-4J4HK5P-1&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=8c0fd5a6f1431a3cbfc9ff2f37470c3b [Accessed August 8, 2009].
**[[Diagnostic_Kits/Patent pools and diagnostic testing|Highlights]]
*Esther van Zimmeren et al. 2006. ''Bulletin of the World Health Organization - A clearing house for diagnostic testing: the solution to ensure access to and use of patented genetic inventions?'' Available at: http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862006000500013 [Accessed August 10, 2009].
**[[Diagnostic_Kits/A clearing house for diagnostic testing: the solution to ensure access to and use of patented genetic inventions|Highlights]]


= Legal tools available for and in use by the actors of Kits' sector: IP in Kits =
= Legal tools available for and in use by the actors of Kits' sector: IP in Kits =

Revision as of 16:53, 17 April 2010

Bibliographic entries used in each research question (1-12; defined by the Field Research Methodology).

Overview of Economics of Intellectual Property in Kits

  • Jensen, K. & Murray, F., 2005. INTELLECTUAL PROPERTY: Enhanced: Intellectual Property Landscape of the Human Genome. Science, 310(5746), 239-240.
  • Mills, A.E. & Tereskerz, P., 2008. DNA-based patents: an empirical analysis. Nat Biotech, 26(9), 993-995.
  • Pressman, L. et al., 2006. The licensing of DNA patents by US academic institutions: an empirical survey. Nat Biotech, 24(1), 31-39

Give an overall picture of the Kits' sector

Outputs and Products of the field: data, narratives and tools produced by the Kits' sector

Legal tools available for and in use by the actors of Kits' sector: IP in Kits

Competitive advantages in Kits

IP Profile of Biggest for-profit companies in Kits

IP Profile of non-profit companies in Kits

IP Profile of Universities working in Kits

  • Pressman, L. et al., 2006. The licensing of DNA patents by US academic institutions: an empirical survey. Nat Biotech, 24(1), 31-39

IP Profile of Associations in Kits

  • Biotechnology Industry Organization (BIO), Available at: http://www.bio.org/ [last accessed April, 17, 2010] (the world's largest biotechnology organization).

Commons based cases in Kits

  • Dequeker, Elisabeth et. al., Quality control in molecular genetic testing, Nature Reviews Genetics 2, 717–723 (1 September 2001).
  • Kalman, Lisa et. al., Development and Characterization of Reference Materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 Genetic Testing, Journal of Molecular Diagnostics 2009, Vol. 11, No. 6
  • Pratt, Victoria. Development of Genomic Reference Materials for Cystic Fibrosis Genetic Testing, Journal of Molecular Diagnostics 2009, Vol. 11, No. 3

Peer-Production Business models in Kits

Open Business models in Kits

  • add entries here